Zurueck zur Suche

Reporte zur Charge EN16208

Verknuepft ueber VAERS_ID mit VAERSDATA, Vax und Symptoms

2Reporte angezeigt
0Todesfaelle
2Hospitalisiert
0Lebensbedrohlich
0Bleibende Schaeden
WV 2

VAERS 1269686

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN16208

moderat
Staat
WV
Alter
39,0
Geschlecht
F
Eingang
29.04.2021
Impfdatum
19.03.2021
Beginn
19.03.2021
Tage bis Beginn
0,0
Dosis
1
Route/Site
- / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein
Blood test Computerised tomogram head Gait inability Hypoaesthesia Hypoaesthesia oral Magnetic resonance imaging head Magnetic resonance imaging neck Magnetic resonance imaging spinal Muscle spasms Muscular weakness Myalgia Paraesthesia Paraesthesia oral Peripheral swelling SARS-CoV-2 test Vitamin D Vitamin D deficiency

Symptomtext

numbness, tingling, and swelling of her hands and feet; numbness, tingling, and swelling of her hands and feet; numbness, tingling, and swelling of her hands and feet; muscle weakness; unable to walk unassisted; Vitamin D deficiency; muscle cramps in her lower extremities that progressed to her upper extremities and neck; muscle soreness in her lower extremities that progressed to her upper extremities and neck; intermittent numbness/tingling of my inner upper lip; intermittent numbness/tingling of my inner upper lip; This is a spontaneous report from a contactable other healthcare professional (HCP) reported for herself. A 39-years-old female patient received bnt162b2 (BNT162B2), dose 1 via an unspecified route of administration, administered in Arm Left on 19Mar2021 (Batch/Lot Number: EN16208) at the age of 39-years-old as single dose for covid-19 immunisation. Patient was not pregnant. Medical history included Hormonal Acne, gastrooesophageal reflux disease (GERD). Prior to vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included spironolactone taken for an unspecified indication, start and stop date were not reported; esomeprazole magnesium (NEXIUM) taken for an unspecified indication, start and stop date were not reported; aluminium hydroxide, magnesium trisilicate, sodium alginate (PEPCID) taken for an unspecified indication, start and stop date were not reported. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient previously took cefalexin monohydrate (KEFLEX) and experienced allergy. The patient initially had some intermittent numbness/tingling of her inner upper lip that began within the first hour of receiving the vaccine on 19Mar2021 and lasted about 24 hours. Six days following vaccination on 25Mar2021, the patient began having muscle cramps/muscle soreness in her lower extremities that progressed to her upper extremities and neck, By the eighth day on 27Mar2021, she had developed numbness, tingling, and swelling of her hands and feet. On this day, she also began having muscle weakness and was unable to walk unassisted by the end of the day. She was seen in the Emergency room (ER), admitted, and transferred to another facility. The patient hospitalized for 1 day. She underwent a Computerised tomogram (CT) scan of my head, Magnetic resonance imaging (MRI) of my brain/neck, lumbar puncture, and extensive blood work. All of her work up was unremarkable except for showing that she had a Vitamin D deficiency. Her symptoms began to improve without treatment in the hospital, and she was discharged home with the diagnosis that she had most likely had an unusual, adverse reaction to her 1st dose of the COVID 19 vaccine and was instructed not to receive my 2nd dose. Covid tested post vaccination (Nasal swab) on 28Mar2021: Negative. The outcome of the events 'numbness/tingling of my inner upper lip' was recovered on 20Mar2021 and the outcome of the other events was recovering.; Sender's Comments: Based on a positive temporal association, a possible contributory role of the suspect BNT162B2 cannot be excluded for the reported Myalgia, Muscle cramps, Hypoasthesia, Parasthesia, Pheripheral swelling, Muscle weakness and Vitamin D Defiency. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to regulatory authorities, Ethics Committees, and Investigators, as appropriate.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Paraesthesia
Hospital-Tage
1,0
Labordaten
Test Date: 20210327; Test Name: blood work; Result Unstructured Data: Test Result:unremarkable; Test Date: 20210327; Test Name: CT Scan head; Result Unstructured Data: Test Result:unremarkable; Test Date: 20210327; Test Name: MRI of brain; Result Unstructured Data: Test Result:unremarkable; Test Date: 20210327; Test Name: MRI of neck; Result Unstructured Data: Test Result:unremarkable; Test Date: 20210327; Test Name: MRI of lumbar puncture; Result Unstructured Data: Test Result:unremarkable; Test Date: 20210328; Test Name: Nasal Swab; Test Result: Negative ; Test Date: 20210327; Test Name: Vitamin D; Result Unstructured Data: Test Result:deficiency
Aktuelle Erkrankungen
-
Vorgeschichte
Medical History/Concurrent Conditions: GERD; Hormonal acne
Andere Medikamente
SPIRONOLACTONE; NEXIUM [ESOMEPRAZOLE MAGNESIUM]; PEPCID [ALUMINIUM HYDROXIDE;MAGNESIUM TRISILICATE;SODIUM ALGINATE]
Allergien
-
Vorherige Impfungen
-

VAERS 1160807

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN16208

moderat
Staat
WV
Alter
39,0
Geschlecht
F
Eingang
02.04.2021
Impfdatum
19.03.2021
Beginn
25.03.2021
Tage bis Beginn
6,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein
Alanine aminotransferase normal Anion gap decreased Anti-cyclic citrullinated peptide antibody negative Antinuclear antibody Antinuclear antibody negative Aspartate aminotransferase normal Asthenia Atrial enlargement Bacterial test negative Basophil count decreased Blood albumin normal Blood alkaline phosphatase normal Blood bilirubin normal Blood calcium decreased Blood chloride normal Blood copper Blood creatine phosphokinase normal Blood creatinine normal

Symptomtext

The first abnormal effect I experienced was numbness in my inner upper lip. This was intermittent and lasted roughly 24-48 hours after vaccine administration. Then on 3/25, I had muscle cramping/soreness in my lower leg muscles (calves). The next day (3/26), the muscle soreness continued, and my lower leg muscles began to feel tight when walking. On 3/27, I woke up with numbness and tingling in my right 5th digit, which then spread to all my fingers and toes. That morning, the muscle soreness had also spread into my thighs and bilateral upper extremities. I also noted mild swelling in my hands and feet and could not put my rings on or wear socks or shoes. By that evening, walking became more difficult as the muscle soreness had now turned into muscle weakness. This prompted me to go the ER for evaluation. A CT scan of my head and lab work was done. I was given IV fluids and sent home with instructions to return to the ER the following day for a MRI of my brain. Overnight, the weakness and swelling in my hands and feet progressed . I became unable to walk, go to the bathroom, or feed my self without assistance. The numbness and tingling I first experienced in my inner upper lip returned, and these symptoms were also now noted in the rest of my face as well. I also began having muscle soreness in my neck, my jaw felt sore when chewing food, and I began seeing some floaters. I returned to the ER the morning of 3/28. They did more blood work, imaging, as well as a lumbar puncture, and I was admitted to hospital. Once admitted, the hospitalist consulted with another hospital and recommended transfer by EMS there where I was admitted under a neurologist's care. When I arrived at that hospital, I began to feel somewhat better as the soreness and swelling appeared to be improving, and I could walk without assistance. They did a full neurological workup and kept me overnight for observation. Overnight, I did experience a mild headache that was relieved with Tylenol and rest. I woke up the next morning (3/29) with nausea and did have a few episodes of vomiting that turned into dry heaving and was given Zofran with relief. The swelling in my hand went down enough that I was able to make a fist and grasp objects with my fingers again. After the neurologist reviewed my labs and work up the morning of 3/29, I was allowed to return home to await final test results as all my tests were looking normal, my symptoms were continuing to improve, and PT had cleared me to be able to return home. Upon discharge, I was instructed to not get my 2nd COVID vaccination as it was possible that my symptoms were an adverse reaction to the COVID vaccination as no other diagnosis was found with testing. I was instructed to follow up with my PCP in one week. Since returning home, I have continued to be very easily fatigued and have had some headaches, nausea, and dizziness. I continue to feel weak when walking and have some muscle stiffness when first waking from sleep. I also continue to have some intermittent episodes of numbness and tingling.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Paraesthesia
Hospital-Tage
1,0
Labordaten
3/29/21 = AST 20 3/29/21, ALT 11, CK 52, 3/28/21 = COVID19 molecular lab testing - negative, ANA serum - negative, SS-A and SS-B serum - normal, DSDNA Ab - negative, Rheumatoid factor serum - <13, Anti-SSB Ab - negative, Anti-SSB Ab quantitative - negative, Copper serum 1.02, Rheumatoid factor titer - negative, Cyclic Citrullinated peptide Ab serum - negative, Mono test - negative, HIV1/HIV2 - negative, CK total serum 39, LDH 151, Vitamin D 12, HgA1c 4.9, Vitamin B12 290, Body Fluid Cell Count with diff -negative (2), MS profile serum and spinal - negative (0.0083), Lyme CSF 0.12, CSF culture - no growth, Protein CSF 31, Glucose CSF 65 Imaging - MRI of spine (cervical) - no stenosis or lesions, X-ray of phalangeal joints - no fracture, erosions, or inflammatory arthritis, MRI brain - normal 3/27/21 = Basic Metabolic - Sodium 137, Potassium 4.0, Chloride 104, CO2 27, Calcium 8.8, Glucose 113, BUN 8, Anion Gap 6, Creatinine 0.57, BUN/Cr ratio 14, GFR >60 HcG Pregnancy - negative, Hepatic Function Panel - Albumin 4.0, Alk Phos. 65, Bilirubin 0.4, Protein 6.5, Troponin-I <0.03, TSH 4.740, Sedimentation Rate 11, C-Reactive Protein 10.8, CBC with diff - WBC 6.6, RBC 4.53, HGB 13.6, HCT 39.9, MCV 88.0, MCH 30.0, MCHC 34.1, RDW 12.8%, platelets 156, MPV 8.1, Neutrophil 5.60, Lymphocyte 0.50, Monocyte 0.40, Eosinophil 0.00, Basophil 0.00 Lyme Antibody panel - negative, IgA 52, ECG - sinus tachycardia/left atrial enlargement/RSR in V1 or V2, right VCD or RVH, CT brain - normal
Aktuelle Erkrankungen
None
Vorgeschichte
None
Andere Medikamente
Spironolactone, Nexium, Famotidine
Allergien
Cephalexin
Vorherige Impfungen
-